Regulations.gov document
Guidance for Industry: Systemic Lupus ErythematosusDeveloping Medical Products for…
Notice · FDA-2005-D-0224 · posted Jun 22, 2010
Key facts
| Document ID | FDA-2005-D-0224-0005 |
|---|---|
| Title | Guidance for Industry: Systemic Lupus ErythematosusDeveloping Medical Products for Treatment; Availability |
| Document type | Notice |
| Subtype | NAD-Notice of Availability of Data |
| Agency | FDA |
| Docket | FDA-2005-D-0224 |
| Posted | Jun 22, 2010 |
| Federal Register citation | 75 FR 35493 |
| FR document number | 2010-15080 |
| Effective date | Jun 22, 2010 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: